Use of pigmented retinal epithelial cells for creation of an immune privilege site

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11363911

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel in vivo method for creation of a localized immunosuppressive environment in tissue. The method involves the transplanting of pigmented retinal epithelial cells into a mammal thereby producing a localized immunosuppressive environment. The transplanted pigmented retinal epithelial cells may also be used to produce therapeutic proteins or other biologically active molecules that may be useful in treatment of diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TITAN PHARMACEUTICALS INCSOMERVILLE NJ

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allen, Richard C Flemington, NJ 113 4195
Cornfeldt, Michael L Morristown, NJ 1 18
Kidwell, William R Ijamsville, MD 1 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation